Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 3
2001 2
2002 1
2004 1
2007 1
2008 3
2010 2
2013 1
2014 1
2020 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Neuropsychiatric reaction induced by abacavir.
Colebunders R, Hilbrands R, De Roo A, Pelgrom J. Colebunders R, et al. Among authors: pelgrom j. Am J Med. 2002 Nov;113(7):616. doi: 10.1016/s0002-9343(02)01259-7. Am J Med. 2002. PMID: 12459415 No abstract available.
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption.
De Scheerder MA, Van Hecke C, Zetterberg H, Fuchs D, De Langhe N, Rutsaert S, Vrancken B, Trypsteen W, Noppe Y, Van Der Gucht B, Pelgrom J, Van Wanzeele F, Palmer S, Lemey P, Gisslén M, Vandekerckhove L. De Scheerder MA, et al. Among authors: pelgrom j. J Antimicrob Chemother. 2020 May 1;75(5):1311-1320. doi: 10.1093/jac/dkaa003. J Antimicrob Chemother. 2020. PMID: 32053203 Free PMC article.
Determinants of adherence in a cohort of Belgian HIV patients: a pilot study.
Degroote S, Vogelaers D, Vermeir P, Mariman A, De Rick A, Van Der Gucht B, Pelgrom J, Van Wanzeele F, Verhofstede C, Vancauwenberghe J, Vandijck D. Degroote S, et al. Among authors: pelgrom j. Acta Clin Belg. 2014 Apr;69(2):111-5. doi: 10.1179/0001551214Z.00000000035. Acta Clin Belg. 2014. PMID: 24724750
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.
Molina JM, Andrade-Villanueva J, Echevarria J, Chetchotisakd P, Corral J, David N, Moyle G, Mancini M, Percival L, Yang R, Thiry A, McGrath D; CASTLE Study Team. Molina JM, et al. Lancet. 2008 Aug 23;372(9639):646-55. doi: 10.1016/S0140-6736(08)61081-8. Lancet. 2008. PMID: 18722869 Clinical Trial.
Impact of Delta 32-CCR5 heterozygosity on HIV-1 genetic evolution and variability--a study of 4 individuals infected with closely related HIV-1 strains.
Chalmet K, Van Wanzeele F, Demecheleer E, Dauwe K, Pelgrom J, Van Der Gucht B, Vogelaers D, Plum J, Stuyver L, Vandekerckhove L, Verhofstede C. Chalmet K, et al. Among authors: pelgrom j. Virology. 2008 Sep 30;379(2):213-22. doi: 10.1016/j.virol.2008.06.036. Epub 2008 Aug 9. Virology. 2008. PMID: 18692212 Free article.
17 results